Work

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation

Year: 2016

Type: article

Study designs: Systematic Review, Meta-Analysis

Source: The American Journal of Medicine

DOI: 10.1016/j.amjmed.2016.05.007

Authors: Giulia Renda, Marco Zimarino, Fabrizio Ricci, Jonathan P. Piccini, Michael D. Ezekowitz, Manesh R. Patel, Riccardo Cappato, Robert P. Giugliano, Raffaele De Caterina

Institutions: University of Chieti-Pescara, Duke Medical Center, Duke Clinical Research Institute, Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, AstraZeneca, Bayer, Merck, Novartis, Roche, American College of Cardiology Foundation, Daiichi-Sankyo, National Heart, Lung, and Blood Institute, Janssen Pharmaceuticals

OpenAlex ID: W2418151246

FWCI: 4.118

Cites: 30

Cited by: 19

Related to: 10